期刊
NEW ENGLAND JOURNAL OF MEDICINE
卷 368, 期 2, 页码 107-116出版社
MASSACHUSETTS MEDICAL SOC
DOI: 10.1056/NEJMoa1211103
关键词
-
资金
- National Institute on Aging [P50-AG025688, U01AG006781]
- Research Council of Norway
- South-Eastern Norway Health Authority
- National Institutes of Health [U01HG004438]
- National Human Genome Research Institute [U01HG004610]
- eMERGE Administrative Coordinating Center [U01HG004603]
- National Center for Biotechnology Information
- Erasmus Medical Center
- Erasmus University, Rotterdam
- Netherlands Organization for Health Research and Development
- Research Institute for Diseases in the Elderly
- Ministry of Education, Culture and Science
- Ministry for Health, Welfare and Sports
- European Commission
- Municipality of Rotterdam
- Research Institute for Diseases in the Elderly [014-93-015]
- Stichting Alzheimer Onder-zoek
- Hersenstichting Nederland
- Netherlands Genomics Initiative-Netherlands Organization for Scientific Research (Center for Medical Systems Biology and the Netherlands Consortium for Healthy Aging)
- Seventh Framework Program
- ENGAGE project [HEALTH-F4-2007-201413]
BACKGROUND Sequence variants, including the epsilon 4 allele of apolipoprotein E, have been associated with the risk of the common late-onset form of Alzheimer's disease. Few rare variants affecting the risk of late-onset Alzheimer's disease have been found. METHODS We obtained the genome sequences of 2261 Icelanders and identified sequence variants that were likely to affect protein function. We imputed these variants into the genomes of patients with Alzheimer's disease and control participants and then tested for an association with Alzheimer's disease. We performed replication tests using case-control series from the United States, Norway, the Netherlands, and Germany. We also tested for a genetic association with cognitive function in a population of unaffected elderly persons. RESULTS A rare missense mutation (rs75932628-T) in the gene encoding the triggering receptor expressed on myeloid cells 2 (TREM2), which was predicted to result in an R47H substitution, was found to confer a significant risk of Alzheimer's disease in Iceland (odds ratio, 2.92; 95% confidence interval [CI], 2.09 to 4.09; P=3.42x10(-10)). The mutation had a frequency of 0.46% in controls 85 years of age or older. We observed the association in additional sample sets (odds ratio, 2.90; 95% CI, 2.16 to 3.91; P=2.1x10(-12) in combined discovery and replication samples). We also found that carriers of rs75932628-T between the ages of 80 and 100 years without Alzheimer's disease had poorer cognitive function than noncarriers (P=0.003). CONCLUSIONS Our findings strongly implicate variant TREM2 in the pathogenesis of Alzheimer's disease. Given the reported antiinflammatory role of TREM2 in the brain, the R47H substitution may lead to an increased predisposition to Alzheimer's disease through impaired containment of inflammatory processes. (Funded by the National Institute on Aging and others.)
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据